FRMO CORP
FRMO
The9 Ltd
NCTY
Argo Blockchain
ARBK
Ebang International
EBON
Intchains Group
ICG
US Stock MarketDetailed Quotes
NKTX Nkarta
- 1.880
- -0.090-4.57%
Close Feb 25 16:00 ET
132.67MMarket Cap-1.03P/E (TTM)
2.000High1.865Low1.18MVolume1.960Open1.970Pre Close2.24MTurnover2.42%Turnover RatioLossP/E (Static)70.57MShares16.24052wk High0.31P/B91.17MFloat Cap1.86552wk Low--Dividend TTM48.50MShs Float79.160Historical High--Div YieldTTM6.85%Amplitude1.280Historical Low1.904Avg Price1Lot Size
About Nkarta Company
Nkarta, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. The firm’s product include NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes, and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company was founded by Dario Campana in 2005 and is headquartered in South San Francisco, CA.
Company Profile
SymbolNKTX
Company NameNkarta
Listing DateJul 10, 2020
Issue Price18.00
Founded2005
CEOMr. Paul J. Hastings
MarketNASDAQ
Employees150
Fiscal Year Ends12-31
Address1150 Veterans Boulevard
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-925-407-1049
Websitehttp://www.nkartatx.com
Company Executives
- Name
- Position
- Salary
- Paul J. Hastings
- Chief Executive Officer and Director
- 2.93M
- Dr. Ralph Brandenberger, PhD
- Chief Technical Officer
- --
- Dr. David R. Shook, M.D.
- Chief Medical Officer and Head of Research and Development
- 1.51M
- Dr. Alicia J. Hager, PhD
- Chief Legal Officer and Corporate Secretary
- --
- Alyssa Levin
- Chief Financial Officer, Chief Business Officer and Principal Accounting Officer
- 1.29M
- Dr. Ali Behbahani, M.B.A.,M.D.
- Chairman of the Board
- 166.75K
- Dr. Nadir Mahmood, PhD
- President
- --
- George Vratsanos, M.D.
- Independent Director
- --
- Dr. Simeon J. George, M.B.A.,M.D.
- Independent Director
- 126.25K
- Angela Thedinga
- Independent Director
- 122.50K
- Leone D Patterson
- Independent Director
- 136.25K
- Dr. Michael Dybbs, PhD
- Independent Director
- 135.25K
- Dr. Zachary Scheiner, PhD
- Independent Director
- 125.25K
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.